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Dabigatran
• Oral • Dosing:
• Therapy:150 mg BID (75 mg bid if CrCl 15-30, none if < 15)
• Prophylaxis 220mg or 110mg dDay • Drug-drug interaction -rifampin (possible also -amiodarone, cyclosporin, clarithromycin, itraconazole, ketoconazole, ritonavir, saquinavir, tacrolimus or verapamil) • No monitoring needed • Approved in Europe for DVT prevention -220 or 150mg daily • Approved for stroke prevention in atrial fibrillation and RCT data for DVT treatment/prevention • Renal clearance -dose reduce if CrCl < 30 and contraindicated CrCl < 15
• Effects aPTT -can use to see if patient still has drug effect -1.5 -2x 0.5-2 hours after dose
• PeaceHealth Labs performs specific dabigatran level • No specific antidote -specific antibody in development
• Consider activated prothrombin complex concentrates (aPCC) or PCC • Can be dialyzed off Enox 40mg/day 35 3.9 8.8* 0.8 0.7 A = Apixaban D = Dabigatran Enox = Enoxaparin R = Rivaroxaban * = significant 
